RESUMEN
To examine the role of metalloproteinases in tissue remodeling associated with wound healing, we used in situ hybridization to localize the expression of collagenase and tissue inhibitor of metalloproteinases (TIMP) in samples of pyogenic granuloma. Strong hybridization for collagenase mRNA was detected in basal keratinocytes near the advancing edge of all ulcerative lesions, but no collagenase mRNA was seen in samples without ulceration. Distinct from the sites of collagenase expression, TIMP mRNA was detected in stromal cells and in cells surrounding proliferating vessels. No collagenase mRNA was found in the epidermis of healthy skin, although occasional stromal cells contained collagenase or TIMP mRNAs, and TIMP mRNA was detected in hair follicles and sebaceous glands. Our results suggest that basal keratinocytes adjacent to wounded epidermis are critically involved in matrix remodeling, much more so than adjacent or underlying dermal fibroblasts. Furthermore, as several reports have suggested, TIMP may play a role in angiogenesis. Finally, in contrast to findings from other models which indicate that collagenase and TIMP proteins are secreted by the same cells, our data also demonstrate that these proteins can be produced in vivo independently of each other.
Asunto(s)
Colagenasas/biosíntesis , Glicoproteínas/biosíntesis , Granuloma/metabolismo , Metaloendopeptidasas/antagonistas & inhibidores , Cicatrización de Heridas , Colagenasas/genética , Glicoproteínas/genética , Humanos , Hibridación in Situ , ARN Mensajero/análisis , Supuración , Inhibidores Tisulares de Metaloproteinasas , Úlcera/metabolismoRESUMEN
We reported that interstitial collagenase is produced by keratinocytes at the edge of ulcers in pyogenic granuloma, and in this report, we assessed if production of this metalloproteinase is a common feature of the epidermal response in a variety of wounds. In all samples of chronic ulcers, regardless of etiology, and in incision wounds, collagenase mRNA, localized by in situ hybridization, was prominently expressed by basal keratinocytes bordering the sites of active re-epithelialization indicating that collagenolytic activity is a characteristic response of the epidermis to wounding. No expression of mRNAs for 72- and 92-kD gelatinases or matrilysin was seen in keratinocytes, and no signal for any metalloproteinase was detected in normal epidermis. Immunostaining for type IV collagen showed that collagenase-positive keratinocytes were not in contact with an intact basement membrane and, unlike normal keratinocytes, expressed alpha 5 beta 1 receptors. These observations suggest that cell-matrix interactions influence collagenase expression by epidermal cells. Indeed, as determined by ELISA, primary cultures of human keratinocytes grown on basement membrane proteins (Matrigel; Collaborative Research Inc., Bedford, MA) did not express significant levels of collagenase, whereas cells grown on type I collagen produced markedly increased levels. These results suggest that migrating keratinocytes actively involved in re-epithelialization acquire a collagenolytic phenotype upon contact with the dermal matrix.
Asunto(s)
Colagenasas/biosíntesis , Matriz Extracelular/fisiología , Granuloma/fisiopatología , Queratinocitos/enzimología , Queratinocitos/fisiología , Úlcera/fisiopatología , Cicatrización de Heridas/fisiología , Membrana Basal/fisiología , Células Cultivadas , Expresión Génica , Granuloma/metabolismo , Granuloma/patología , Humanos , Inmunohistoquímica , Integrinas/biosíntesis , Sondas ARN , Úlcera/metabolismo , Úlcera/patologíaRESUMEN
Wound repair involves cell migration and tissue remodeling, and these ordered and regulated processes are facilitated by matrix-degrading proteases. We reported that interstitial collagenase is invariantly expressed by basal keratinocytes at the migrating front of healing epidermis (Saarialho-Kere, U. K., E. S. Chang, H. G. Welgus, and W. C. Parks, 1992. J. Clin. Invest. 90:1952-1957). Because of the limited substrate specificity of collagenase, principally for interstitial fibrillar collagens, other enzymes must also be produced in the wound environment to effectively restructure tissues with a complex matrix composition. Stromelysins-1 and -2 are closely related, yet distinct metalloproteinases, and both can degrade many noncollagenous connective tissue macromolecules. Using in situ hybridization and immunohistochemistry, we found that both stromelysins are produced by distinct populations of keratinocytes in a variety of chronic ulcers. Stromelysin-1 mRNA and protein were detected in basal keratinocytes adjacent to but distal from the wound edge in what probably represents the sites of proliferating epidermis. In contrast, stromelysin-2 mRNA was seen only in basal keratinocytes at the migrating front, in the same epidermal cell population that expresses collagenase. Stromelysin-1-producing keratinocytes resided on the basement membrane, whereas stromelysin-2-producing keratinocytes were in contact with the dermal matrix. Furthermore, stromelysin-1 expression was prominent in dermal fibroblasts, whereas no signal for stromelysin-2 was seen in any dermal cell. These findings demonstrate that stromelysins-1 and -2 are produced by different populations of basal keratinocytes in response to wounding and suggest that these two matrix metalloproteinases serve distinct roles in tissue repair.
Asunto(s)
Queratinocitos/metabolismo , Metaloendopeptidasas/biosíntesis , Cicatrización de Heridas , Células Cultivadas , Enfermedad Crónica , Colagenasas/biosíntesis , Colagenasas/genética , Fibroblastos/metabolismo , Humanos , Metaloproteinasa 10 de la Matriz , Metaloproteinasa 3 de la Matriz , Metaloendopeptidasas/genética , ARN Mensajero/análisis , Úlcera/metabolismoRESUMEN
We report that matrilysin, a matrix metalloproteinase, is constitutively expressed in the epithelium of peribronchial glands and conducting airways in normal lung. Matrilysin expression was increased in airway epithelial cells and was induced in alveolar type II cells in cystic fibrosis. Other metalloproteinases (collagenase-1, stromelysin-1, and 92-kD gelatinase) were not produced by normal or injured lung epithelium. These observations suggest that matrilysin functions in injury-mediated responses of the lung. Indeed, matrilysin expression was increased in migrating airway epithelial cells in wounded human and mouse trachea. In human tissue, epithelial migration was reduced by > 80% by a hydroxamate inhibitor, and in mouse tissue, reepithelialization in trachea from matrilysin-null mice was essentially blocked. In vivo observations and cell culture studies demonstrated that matrilysin was secreted lumenally by lung epithelium, but upon activation or while migrating over wounds, some matrilysin was released basally. The constitutive production of matrilysin in conducting airways, its upregulation after injury, its induction by alveolar epithelium, and its release into both lumenal and matrix compartments suggest that this metalloproteinase serves multiple functions in intact and injured lung, one of which is to facilitate reepithelialization.
Asunto(s)
Células Epiteliales/enzimología , Pulmón/enzimología , Metaloendopeptidasas/genética , Metaloendopeptidasas/metabolismo , Tráquea/enzimología , Amidas/farmacología , Animales , Movimiento Celular/efectos de los fármacos , Fibrosis Quística/enzimología , Inducción Enzimática , Células Epiteliales/citología , Células Epiteliales/fisiología , Femenino , Regulación Enzimológica de la Expresión Génica , Humanos , Pulmón/citología , Pulmón/patología , Enfermedades Pulmonares/enzimología , Enfermedades Pulmonares/patología , Neoplasias Pulmonares/enzimología , Neoplasias Pulmonares/patología , Metaloproteinasa 7 de la Matriz , Metaloendopeptidasas/biosíntesis , Ratones , Ratones Noqueados , Inhibidores de Proteasas/farmacología , Alveolos Pulmonares/enzimología , Acetato de Tetradecanoilforbol/farmacología , Tráquea/citología , Tráquea/lesiones , Células Tumorales Cultivadas , Tirosina/análogos & derivados , Tirosina/farmacologíaRESUMEN
We studied the temporal expression of interstitial collagenase, stromelysin-1 and -2, and urokinase plasminogen activator (uPA) mRNAs by in situ hybridization in eight patients with dermatitis herpetiformis. To induce blisters, 50% potassium iodide patch tests were performed, and serial biopsy specimens were taken at 4, 12, and 24 h. Additional samples were taken from occasional spontaneous blisters. Components of the basement membrane, laminin-5, laminin-1, and type VII collagen, were examined immunohistochemically in relation to matrix metalloproteinase expression. At 12 h, when no blisters were seen, uPA mRNA was present in basal keratinocytes in five of eight samples, whereas interstitial collagenase and stromelysin-1 mRNA were not detected. At this time, immunohistochemistry failed to show changes in the basement membrane. At 24 h, uPA, collagenase, and stromelysin-1 mRNAs were present in basal keratinocytes, suggesting an activation of latent forms of the two latter enzymes by the uPA-plasmin pathway. Signal for stromelysin-2 was not detected. Furthermore, disruptions of laminin-1 and type VII collagen were evident. The data suggest that stromelysin-1 and interstitial collagenase may contribute to the degradation of basement membrane in dermatitis herpetiformis. Intracellular staining for laminin-5 co-localized with collagenase mRNA in basal keratinocytes. Because laminin-5 is essential for adhesion of keratinocytes to basement membrane and for establishment of focal adhesions on migrating cells, its production may reflect a regenerative response after the destruction of basement membrane components.
Asunto(s)
Colagenasas/genética , Dermatitis Herpetiforme/metabolismo , Laminina/genética , Metaloproteinasa 3 de la Matriz/genética , Activador de Plasminógeno de Tipo Uroquinasa/genética , Colágeno/biosíntesis , Dermatitis Herpetiforme/genética , Humanos , Inmunohistoquímica , Hibridación in Situ , Queratinocitos/química , Metaloproteinasa 1 de la Matriz , ARN Mensajero/análisis , Factores de TiempoRESUMEN
Because dermatitis herpetiformis is characterized by neutrophilic inflammation and destructive changes in the basement membrane zone, we studied the in situ expression of interstitial collagenase and stromelysin-1 in 11 lesions. A prominent signal for collagenase mRNA was consistently detected in the basal keratinocytes of rete ridges surrounding the neutrophilic abscesses in 10 of 11 lesions, and the expression was independent of the age of the lesion and the migratory state of the basal keratinocytes. Expression of stromelysin-1 was detected in seven of 11 lesions and co-localized with collagenase. No expression of the 92-kDa gelatinase mRNA or matrilysin protein was found in the vicinity of neutrophilic accumulations or the damaged basement membrane. Urokinase-type plasminogen activator mRNA was found in basal keratinocytes in seven of nine samples. Collagenase, stromelysin-1, and urokinase-type plasminogen activator were not expressed in normal-appearing skin of patients with dermatitis herpetiformis. Our results suggest that in lesions of dermatitis herpetiformis, collagenase and stromelysin-1 may be induced in basal keratinocytes by neutrophil cytokines or by altered cell-matrix interactions through contact of keratinocytes with the matrix due to damaged basement membrane. Stromelysin-1, in particular, may contribute to formation of blisters by degrading basement membrane components.
Asunto(s)
Colagenasas/metabolismo , Dermatitis Herpetiforme/metabolismo , Metaloendopeptidasas/metabolismo , Activador de Plasminógeno de Tipo Uroquinasa/metabolismo , Colagenasas/genética , Dermatitis Herpetiforme/patología , Espacio Extracelular/metabolismo , Gelatinasas/metabolismo , Glicoproteínas/metabolismo , Humanos , Inmunohistoquímica , Queratinocitos/metabolismo , Metaloproteinasa 3 de la Matriz , Metaloendopeptidasas/genética , Inhibidores Tisulares de Metaloproteinasas , Activador de Plasminógeno de Tipo Uroquinasa/genéticaRESUMEN
The proteolytic activity of matrix metalloproteinases is involved in normal and disease-related remodeling processes. One member of this family, matrilysin, can degrade a wide spectrum of connective tissue proteins, suggesting that this enzyme is involved in numerous and diverse biologic processes. In fact, recent studies have shown that matrilysin is expressed in developing hair follicles and glands. Using in situ hybridization and immunohistochemistry, we examined the sites of matrilysin expression in normal and diseased adult skin. In normal mature skin, matrilysin mRNA and protein was strongly and consistently expressed in ductal cells and in some secretory cells of all eccrine and apocrine glands and was not found in any other cell type. A similar tissue distribution was also found in numerous benign inflammatory skin lesions, and prominent expression of matrilysin mRNA and protein was also found in glandular disorders such as axillary hidradenitis and sweat gland tumors. These findings indicate that matrilysin is a constitutive product of the epithelium of dermal glands and that its expression may not be related to a disease-specific or remodeling process. Because of its extensive expression in dermal glands, we assessed whether matrilysin might be produced by all exocrine glands. Indeed, we detected matrilysin mRNA and immunoreactive protein in the ductal and glandular epithelium of mammary and parotid glands, pancreas, liver, prostate, and the serous acini of peribronchial glands of the lung. Thus, our findings indicate that matrilysin is constitutively produced by exocrine epithelial cells throughout the body. Because of its broad catalytic activity, we speculate matrilysin may participate in the normal function of exocrine glands by preventing glandular obstruction.
Asunto(s)
Glándulas Exocrinas/enzimología , Metaloendopeptidasas/metabolismo , Adulto , Epitelio/enzimología , Humanos , Inmunohistoquímica , Hibridación in Situ , Metaloproteinasa 7 de la Matriz , Piel/enzimologíaRESUMEN
Granuloma annular (GA) and necrobiosis lipoidica diabeticorum (NLD) are disorders characterized by granulomatous inflammation and degenerative changes in collagen and elastic fibers. Because these disorders have often been described as being associated with altered extracellular matrix deposition, we studied the in situ expression of interstitial collagenase, 92-kDa gelatinase, and tissue inhibitor of metalloproteinases (TIMP)-1. Twelve lesions each of GA and NLD of different histopathologic types and durations were examined. Interstitial collagenase mRNA was seen in histiocyte-like cells in one-third of the cases of both diseases, typically in younger lesions. In GA, collagenase mRNA was only detected in lesions of the palisading type. Signal for 92-kDa gelatinase mRNA was observed in eosinophils, which were present in low numbers in five of 12 GA and three of 12 NLD samples. The signal for this enzyme and the presence of eosinophils did not correlate with the age of lesion. TIMP-1 mRNA was consistently expressed by histiocyte-like cells in both disorders. In GA, TIMP-1 mRNA was detected at the outer edge of the palisading granulomas, but in NLD, inhibitor expression was seen in the perivascular and periadnexal accumulation of inflammatory cells. Our data indicate that collagenase and TIMP are expressed early in these disorders and that these proteins may contribute to stromal remodeling associated with necrobiotic lesions. Our results further indicate that the localization of TIMP-1 production may provide a distinction between the two disorders, whereas metalloproteinase expression is not sufficiently specific to aid in the differential diagnosis of GA and NLD.
Asunto(s)
Colagenasas/fisiología , Glicoproteínas/fisiología , Granuloma Anular/enzimología , Inhibidores de la Metaloproteinasa de la Matriz , Necrobiosis Lipoidea/enzimología , Adulto , Anciano , Eosinófilos/enzimología , Femenino , Gelatinasas , Humanos , Inmunohistoquímica , Hibridación in Situ , Masculino , Metaloendopeptidasas/fisiología , Persona de Mediana Edad , Pepsina A/sangre , Inhibidores Tisulares de MetaloproteinasasRESUMEN
Co-expression of several members of the matrix metalloproteinase (MMP) family is a characteristic of human carcinomas. To investigate the role of the recently cloned collagenase-3 (MMP-13) in epidermal tumors, we studied samples representing malignant (basal and squamous cell carcinoma, Paget's disease), pre-malignant (Bowen's disease, solar keratosis), and benign (keratoacanthoma, seborrheic keratosis, linear epidermal nevus) tumors. Basal cell carcinomas expressed collagenase-3 mRNA in focal areas of keratinized cells, the squamous differentiation of which was confirmed by positive immunostaining for involucrin. Apoptosis was observed in central parts of these foci. In squamous cell carcinomas, collagenase-3 expression was detected at the epithelial tumor front and less frequently in the surrounding stromal cells. Collagenase-3 mRNA co-localized with immunostaining for laminin-5, an adhesion molecule suggested to participate in the migration of tumor cells. The pre-malignant and benign tumors were mostly negative for collagenase-3. Stromelysin-1, a potential activator of latent collagenases, was frequently expressed by stromal cells surrounding the malignant tumors, and the two MMPs occasionally co-localized in keratotic foci. Our results demonstrate that in basal cell carcinomas, expression of collagenase-3 is associated with terminal differentiation of epithelial cells. Furthermore, the gene is activated during skin carcinogenesis, and we suggest a role for collagenase-3 in degradation of the extracellular matrix associated with malignant epithelial growth.
Asunto(s)
Carcinoma de Células Escamosas/genética , Colagenasas/genética , Neoplasias de Cabeza y Cuello/genética , Neoplasias Cutáneas/genética , Membrana Basal/química , Carcinoma Basocelular/enzimología , Carcinoma Basocelular/genética , Carcinoma de Células Escamosas/enzimología , Moléculas de Adhesión Celular/análisis , Colágeno/análisis , Colagenasas/fisiología , Epitelio/enzimología , Matriz Extracelular/metabolismo , Expresión Génica , Marcadores Genéticos/fisiología , Neoplasias de Cabeza y Cuello/enzimología , Humanos , Inmunohistoquímica , Metaloproteinasa 13 de la Matriz , Metaloproteinasa 3 de la Matriz/genética , Enfermedad de Paget Extramamaria/enzimología , Enfermedad de Paget Extramamaria/genética , Lesiones Precancerosas/genética , Sondas ARN/análisis , ARN Mensajero/metabolismo , Piel/enzimología , Neoplasias Cutáneas/enzimología , KalininaRESUMEN
Migrating keratinocytes actively involved in reepithelialization in dermal wounds acquire a collagenolytic phenotype upon contact with the dermal matrix. To determine whether this phenotype is associated with repair in other forms of wounds, we assessed collagenase expression in 50 specimens representing a variety of blistering skin diseases, including subtypes of epidermolysis bullosa, porphyria cutanea tarda, bullous pemphigoid, pemphigus, transient acantholytic dermatosis, and suction blisters. Distinct from that seen in chronic ulcers or in normal healing by second intention, reepithelialization in these blistering conditions was not necessarily associated with a complete loss of basement membrane, as determined by immunostaining for type IV collagen. Collagenase mRNA was detected in the basal keratinocytes of several specimens of epidermolysis bullosa simplex (six of 10) and of pemphigus (three of seven), as well as in one quarter of transient acantholytic dermatosis samples in the presence of an intact basement membrane. In contrast, three of nine porphyria cutanea tarda, one third of epidermolysis bullosa acquisita, and one of 10 bullous pemphigoid samples had collagenase-positive basal keratinocytes with the basement membrane disrupted. The collagenase-positive lesions generally represented older blisters with evidence of epithelial regeneration. Collagenase was also expressed in suction blisters at 2 and 5 d after induction of the blister, but was shut off when the epidermis had healed. Other metalloproteinases were expressed occasionally, if at all. Our results suggest that keratinocyte migration is associated with collagenase expression and that contact of keratinocytes with the dermal matrix is not necessarily needed for collagenase induction.
Asunto(s)
Colagenasas/biosíntesis , Queratinocitos/enzimología , Enfermedades Cutáneas Vesiculoampollosas/enzimología , Membrana Basal/química , Colágeno/análisis , Colagenasas/genética , Inducción Enzimática , Epidermis/fisiología , Epidermólisis Ampollosa/enzimología , Epitelio/metabolismo , Humanos , Hibridación in Situ , Metaloproteinasa 1 de la Matriz , Metaloproteinasa 3 de la Matriz , Metaloendopeptidasas/genética , ARN Mensajero/análisis , Regeneración , Coloración y EtiquetadoRESUMEN
We studied the expression and regulation of TIMP-3, a recently cloned member of the tissue inhibitor of the metalloproteinase family, during human fetal development and in various human tissues, with emphasis on epithelial structures. Expression of TIMP-3 mRNA was detected by in situ hybridization in developing bone, kidney, and various mesenchymal structures. At 16 weeks of gestation, ectoderm-derived cells of hair germs expressed TIMP-3 mRNA, and beginning from the twentieth week consistent expression was detected in epithelial outer root sheath cells of growing hair follicles. In normal adult human skin, expression of TIMP-3 mRNA was limited to hair follicles, starting at the early anagen (growing) phase and vanishing at the catagen (regressing) phase. TIMP-3 mRNA was not detected in benign hair follicle-derived tumors but was present in tumor cells of infiltrative basal cell carcinomas and in surrounding stromal cells in squamous cell carcinomas. Human primary keratinocytes in culture expressed TIMP-3 mRNAs, the levels of which were upregulated by transforming growth factor-beta (TGF-beta), whereas interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) had no effect. Our results suggest a role for TIMP-3 in connective tissue remodeling during fetal development, hair growth cycle, and cancer progression.
Asunto(s)
Feto/metabolismo , Folículo Piloso/metabolismo , Inhibidores de Proteasas/metabolismo , Neoplasias Cutáneas/metabolismo , Inhibidor Tisular de Metaloproteinasa-3/metabolismo , Adulto , Northern Blotting , Huesos/embriología , Huesos/metabolismo , Carcinoma Basocelular/metabolismo , Carcinoma de Células Escamosas/metabolismo , Cartílago/embriología , Cartílago/metabolismo , Células Cultivadas , Tejido Conectivo/embriología , Tejido Conectivo/metabolismo , Folículo Piloso/embriología , Folículo Piloso/crecimiento & desarrollo , Humanos , Hibridación in Situ , Interleucina-1/farmacología , Queratinocitos/efectos de los fármacos , Queratinocitos/metabolismo , Riñón/embriología , Riñón/metabolismo , Mesodermo/metabolismo , ARN Mensajero/análisis , Neoplasias Cutáneas/patología , Factores de Tiempo , Distribución Tisular , Factor de Crecimiento Transformador beta/farmacología , Factor de Necrosis Tumoral alfa/farmacologíaRESUMEN
Anhidrotic ectodermal dysplasia (EDA) is characterized by defects in the development of teeth, hair, and sweat glands. To study the expression of the human gene defective in EDA in human fetal development (Weeks 6-23 of gestational age) and in adult tissues, in situ hybridization and immunohistochemistry were used. First signs of expression were detected at Week 8 in epidermis and in neuroectodermal cells. Starting at Week 12, osteoblasts and thymus were positive for EDA mRNA. Hair follicles expressed EDA mRNA from 18 weeks. The presence of the EDA protein coincided with mRNA expression in the tissues examined. The expression pattern of the EDA gene is consistent with typical involvement of the skin in the syndrome. However, the expression is not limited to the ectodermal tissues and many sites of expression are not obviously reflected in the clinical features of the syndrome.
Asunto(s)
Huesos/metabolismo , Sistema Nervioso Central/metabolismo , Displasia Ectodérmica/genética , Piel/metabolismo , Timo/metabolismo , Adulto , Huesos/citología , Huesos/embriología , Sistema Nervioso Central/embriología , Displasia Ectodérmica/metabolismo , Folículo Piloso/embriología , Folículo Piloso/metabolismo , Humanos , Inmunohistoquímica , Hibridación in Situ , ARN Mensajero/análisis , Sistema Respiratorio/metabolismo , Piel/embriología , Timo/embriología , Factores de Tiempo , Distribución TisularRESUMEN
Controlled proteolysis is needed for cell migration, angiogenesis, and matrix remodeling during normal wound repair. Our objective has been to investigate how chronic leg ulcers differ from normally healing wounds (pinch graft donor sites) with respect to their metalloproteinase expression patterns. Using in situ hybridization and immunohistochemistry, we found that collagenase-1 (MMP-1), stromelysin-1 (MMP-3) and stromelysin-2 (MMP-10) were expressed in keratinocytes bordering both acute and chronic wounds. Unlike MMP-1, signal for collagenase-3 (MMP-13) was not detected in keratinocytes but exclusively in fibroblasts deep in the ulcer bed of chronic wounds, suggesting that while MMP-1 production is important for migration, MMP-13 plays a role in matrix remodeling. Tissue inhibitor of metalloproteinase (TIMP)-1 was not detected in the epidermis of any chronic wound sample while it was expressed in keratinocytes bordering normally healing wounds. TIMP-3 was abundantly expressed in stromal fibroblast- and macrophage-like cells surrounding vessels and sweat glands in both types of wounds. Our results suggest that there are no qualitative differences in the expression of MMPs-1, -3 and -10 in the epidermis of chronic vs normally healing wounds. However, the number of stromal cells expressing MMP-1 and MMP-3 was greater in chronic vs acute wounds, whereas MMP-10 was never detected in the dermis. TIMP-1 expression near the basement membrane in acute, but not in chronic, wounds suggests that the balance between MMPs and their inhibitors may be altered in poorly healing wounds. Analogous to chronic cutaneous wounds, MMP-1 and -3 are abundantly expressed in chronic small and large bowel ulcers, while the migrating surface epithelium is negative for TIMP-1 expression.
Asunto(s)
Metaloendopeptidasas/metabolismo , Úlcera Cutánea/enzimología , Inhibidores Tisulares de Metaloproteinasas/metabolismo , Animales , Enfermedad Crónica , Humanos , Inmunohistoquímica , Hibridación in Situ , Queratinocitos/enzimología , Cicatrización de HeridasRESUMEN
The pathogenesis of venous leg ulcers is multifactorial. In this review article new physiological, molecular and cellular abnormalities in venous ulcers related to the chronic inflammation are presented and discussed. Venous hypertension causes disturbed microcirculation and pathological changes of the capillaries, which eventually locks the condition in a self-amplifying, detrimental cascade with persistent elevated levels and activities of pro-inflammatory cytokines and proteases preventing progress into a healing phase. As a consequence fibroblasts senescence and become less responsive to growth factors the older the ulcers become. Current data imply there is no deficiency but rather an unfavorable distribution of growth factors in venous ulcers. An imbalance in proteolytic enzymes and their endogenous inhibitors is a common finding in chronic venous leg ulcers. Variation in disease severity and concomitant ailments in this heterogeneous patient group may explain the contradictory results in the literature. Thus, to advance the areas of research further, longitudinal studies involving larger number of patients are required to identify the major pathogenic factors.
Asunto(s)
Úlcera Varicosa/etiología , Úlcera Varicosa/fisiopatología , Enfermedad Crónica , Citocinas/metabolismo , Endopeptidasas/metabolismo , Fibroblastos/patología , Sustancias de Crecimiento/metabolismo , Humanos , Inflamación , Pierna/irrigación sanguínea , Estudios Longitudinales , Inhibidores de Proteasas/metabolismo , Insuficiencia Venosa/etiología , Insuficiencia Venosa/fisiopatologíaRESUMEN
We studied the mechanisms that govern the expression of interstitial collagenase and 92-kDa gelatinase in U937 cells, a human monocyte-like cell line, exposed to bacterial lipopolysaccharide (LPS), a potent inducer of metalloproteinase expression. U937 cells were differentiated by phorbol ester (phorbol 12-myristate 13-acetate (PMA)) and, 24 h later, were exposed to LPS for an additional 24 h. Enzyme-linked immunosorbent assay and Northern hybridization showed that PMA mediated an induction of collagenase and markedly stimulated the low basal levels of 92-kDa gelatinase. Subsequent exposure to LPS substantially increased the production of both enzymes. Nuclear runoff assay demonstrated that PMA regulated collagenase and 92-kDa gelatinase transcription. LPS also stimulated collagenase transcription but did not affect transcription of 92-kDa gelatinase. Consistent with the runoff data, the decay rate of collagenase mRNA did not differ between experimental treatments, but the half-life of gelatinase mRNA increased with exposure to LPS. Furthermore, in situ hybridization showed that 92-kDa gelatinase was expressed by all cells whereas collagenase was produced by a subpopulation of cells in both PMA- and PMA/LPS-exposed cultures, and similar findings were seen with LPS-activated human alveolar macrophages. These data indicate that divergent mechanisms control metalloproteinase expression in phagocytic cells and that enzyme production differs among macrophage subpopulations.
Asunto(s)
Colagenasas/genética , Endopeptidasas/genética , Monocitos/enzimología , Adulto , Animales , Secuencia de Bases , Línea Celular , Colagenasas/biosíntesis , Cicloheximida/farmacología , ADN , Endopeptidasas/biosíntesis , Gelatinasas , Humanos , Hibridación in Situ , Lipopolisacáridos/farmacología , Datos de Secuencia Molecular , Monocitos/citología , ARN Mensajero/metabolismo , Acetato de Tetradecanoilforbol/farmacología , Transcripción GenéticaRESUMEN
Upon exposure to 12-O-tetradecanoylphorbol 13-acetate (PMA), promonocyte-like U937 cells differentiate into macrophage-like cells and begin to express certain metalloproteinases and TIMP-1. We report here that distinct mechanisms regulate TIMP-1 production in PMA-treated U937 cells. TIMP-1 protein and steady-state mRNA levels increased about 10-fold in PMA-differentiated cells compared to undifferentiated cells. TIMP-1 transcription increased about 2.5-fold, but this stimulation was not detected until at least 48 h post-PMA. In contrast, the half-life for TIMP-1 mRNA increased about 3-fold and was detected at 8 h post-PMA. Using in vitro translation assays, we found that TIMP-1 mRNA from PMA-differentiated cells translated about 5-fold less efficiently than that from basal cells, suggesting structural differences in TIMP-1 mRNA in basal and differentiated U937 cells. Although primer extension and RNase protection analyses showed 5' heterogeneity of TIMP-1 transcripts, all forms were equally stimulated in response to PMA-mediated differentiation. The poly(A) tail length of TIMP-1 mRNA, however, was longer in PMA-treated cells. Our findings suggested that up-regulation of TIMP-1 expression in PMA treated U937 cells is mediated early by enhanced TIMP-1 mRNA stability, possibly related to increased poly(A) tail length, and later by an increase in transcription rate.
Asunto(s)
Glicoproteínas/biosíntesis , Metaloendopeptidasas/antagonistas & inhibidores , Monocitos/efectos de los fármacos , Monocitos/metabolismo , Inhibidores de Proteasas/metabolismo , Acetato de Tetradecanoilforbol/farmacología , Diferenciación Celular/efectos de los fármacos , Línea Celular , Dexametasona/farmacología , Glicoproteínas/genética , Humanos , Inhibidores de la Metaloproteinasa de la Matriz , Monocitos/citología , Poli A/metabolismo , Biosíntesis de Proteínas , ARN Mensajero/metabolismo , Inhibidores Tisulares de Metaloproteinasas , Transcripción Genética/efectos de los fármacosRESUMEN
Matrix metalloproteinases (MMPs) degrade extracellular proteins during epithelialization of wounds. To evaluate the biological significance of MMPs in epidermal healing, the synthetic broad-spectrum MMP inhibitor GM 6001 (also called Galardin and Ilomastat) was applied topically to standardized human wounds. GM 6001 (10 microg/microl) or vehicle alone was applied every second day onto 4 de-roofed 6 mm suction blister wounds on the volar forearm of healthy male volunteers for 12 days. GM 6001 delayed healing by 2-4 days as assessed macroscopically and microscopically. In situ hybridization or immunohistochemistry showed that MMP-1 (interstitial collagenase) was present in and MMP-2 (gelatinase A) close to laterally migrating keratinocytes whereas MMP-9 (gelatinase B) was seen during maturation of new epidermis. MMP-1 was undetectable in blister roofs (normal epidermis) and found in low levels in normal skin. Total MMP-1 activities increased about 100-fold in wounds, independent of treatment, compared to normal skin as analyzed by specific ELISA-based activity assay. By gelatin zymography, MMP-2, but not MMP-9, was detected in blister roofs and wound healing was associated with increased active MMP-2 and latent MMP-9 levels. GM 6001 prevented activation of MMP-2 and increased latent MMP-9 levels. GM 6001 delayed re-appearance of laminin-5, the synthesis of which correlated with epidermal regeneration. Restoration of stratum corneum, measured indirectly by transepidermal water loss, was also impaired (P<0.05) in the GM 6001 group. In conclusion, pharmacological MMP inhibition delayed epidermal regeneration in vivo, suggesting that MMPs are required to restore epidermis after epidermal ablation in humans.
Asunto(s)
Vesícula/fisiopatología , Dipéptidos/farmacología , Inhibidores Enzimáticos/farmacología , Epidermis/efectos de los fármacos , Epidermis/fisiopatología , Inhibidores de la Metaloproteinasa de la Matriz , Regeneración/efectos de los fármacos , Cicatrización de Heridas/efectos de los fármacos , Adulto , Vesícula/etiología , Vesícula/patología , Moléculas de Adhesión Celular/metabolismo , Epidermis/patología , Humanos , Inmunohistoquímica , Hibridación in Situ , Masculino , Metaloproteinasa 1 de la Matriz/metabolismo , Metaloproteinasa 2 de la Matriz/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Persona de Mediana Edad , Succión , Factores de Tiempo , KalininaRESUMEN
The present study was carried out to characterize the patterns of expression of matrix metalloproteinases or their tissue inhibitor (TIMP-1) in normally healing, acute vs. chronic, skin wounds. In situ hybridization was performed to localize collagenase, stromelysin-1, stromelysin-2, matrilysin, urokinase plasminogen activator (uPA) and TIMP-1 mRNAs in 14 chronic venous ulcers and 10 normally healing wounds, representing different time points after wounding. Surgical wounds, made in piglets harvested at several time points, were studied as controls. Collagenase, stromelysin-1 and -2, as well as uPa, were expressed in keratinocytes in both acute and chronic wounds, while epithelial TIMP-1 mRNA was not detected in any chronic wound biopsies studied. However, TIMP-1 was expressed at the epithelial edges of both acute human and pig wounds. Our results suggest that the balance between metalloenzymes and their inhibitor TIMP-1, is disturbed, in poorly healing wounds.
Asunto(s)
Glicoproteínas/metabolismo , Inhibidores de la Metaloproteinasa de la Matriz , Metaloendopeptidasas/metabolismo , Piel/lesiones , Cicatrización de Heridas/fisiología , Enfermedad Aguda , Anciano , Anciano de 80 o más Años , Enfermedad Crónica , Femenino , Humanos , Técnicas para Inmunoenzimas , Hibridación in Situ , Masculino , Persona de Mediana Edad , Piel/metabolismo , Inhibidores Tisulares de Metaloproteinasas , Úlcera Varicosa/metabolismoRESUMEN
Programmed expression of several matrix metalloproteinases is an important feature of cutaneous wound healing. To study whether this also applies to gastrointestinal ulcer healing, we used in situ hybridization with 35S-labeled probes to localize sites of collagenase, stromelysin-1, and matrilysin expression in 26 samples representing peptic ulcers, Crohn's disease, and ulcerative colitis. In contrast to skin wounds, collagenase mRNA was not detected in the surface epithelium bordering gastrointestinal ulcer areas. However, together with stromelysin-1 mRNA, it was abundantly expressed by the granulation tissue in all types of ulcers. Signal for matrilysin mRNA and protein was detected in the mucosal epithelium bordering the ulcerations but never in the ulcer stroma. The gut basement membrane was disrupted under the matrilysin-producing epithelial cells as assessed by immunostaining for laminin. Tissue inhibitor of metalloproteinases (TIMP-1) mRNA never co-localized with matrilysin-positive mucosal epithelial cells. These data indicate that matrilysin plays a significant role in epithelial remodelling occurring in gastrointestinal ulcerations whereas collagenase and stromelysin-1 are involved in the reparative processes in the ulcer bed.
Asunto(s)
Colagenasas/biosíntesis , Úlcera Duodenal/enzimología , Enfermedades Inflamatorias del Intestino/enzimología , Metaloendopeptidasas/biosíntesis , Úlcera Gástrica/enzimología , Adulto , Colitis Ulcerosa/enzimología , Colitis Ulcerosa/patología , Enfermedad de Crohn/enzimología , Enfermedad de Crohn/patología , Úlcera Duodenal/patología , Enteritis/enzimología , Enteritis/patología , Mucosa Gástrica/enzimología , Glicoproteínas/biosíntesis , Tejido de Granulación/enzimología , Humanos , Inmunohistoquímica , Hibridación in Situ , Enfermedades Inflamatorias del Intestino/patología , Mucosa Intestinal/enzimología , Metaloproteinasa 3 de la Matriz , Metaloproteinasa 7 de la Matriz , Inhibidores de la Metaloproteinasa de la Matriz , Inhibidores de Proteasas/metabolismo , Sondas ARN , ARN Mensajero/análisis , ARN Mensajero/genética , Estudios Retrospectivos , Úlcera Gástrica/patología , Inhibidores Tisulares de MetaloproteinasasRESUMEN
Since proteolysis of the dermal collagenous matrix and basement membranes is required for local invasive growth and early metastasis formation of cutaneous melanomas, we have analysed the activities/expression levels of certain metalloproteinases in melanomas and cultured melanoma cells by in situ hybridization and Northern analysis. In addition to collagenases-1 and -3 that have been implicated in invasive growth behaviour of various malignant tumours, we analysed the levels of 72-kDa gelatinase and its activators MT1-MMP and TIMP-2 in cultured melanoma cells. The lesions examined included three cases of lentigo maligna and 28 cases of Clark grade I-V melanomas. The premalignant as well as the grade I tumours were consistently negative for collagenase-1 and -3 and TIMP-1 and -3. The collagenases were predominantly expressed in the cancer cells of Clark grade III and IV tumours. TIMP-1 and -3 were abundantly expressed in the cancer and/or stromal cells of grade III and IV melanomas, while TIMP-2 protein was detected also in melanomas representing lower invasive potential. Northern analysis of seven melanoma cell lines showed that the expression of collagenase-1 and TIMPs-1 and -3 was associated with 72-kDa gelatinase positivity. All melanoma cell lines were positive for MT1-MMP and TIMP-2 mRNAs. Our results suggest that overexpression of collagenases-1 and -3 and TIMPs-1 and -3 is induced during melanoma progression. Expression of TIMPs may reflect host response to tumour invasion in an effort to control MMP activity and preserve extracellular matrix integrity.